Your Health, We Care
Most common (>20%) adverse reactions, including laboratory abnormalities were leukopenia, lymphopenia, thrombocytopenia, diarrhea, anemia, rash, musculoskeletal pain, nail toxicity, neutropenia, dry skin, stomatitis, fatigue, and cough.
from FDA，2022.10
The development of cancer treatment drugs has brought hope to patients, but it h···【more】
Release date：2025-03-10Recommended：80
Osimertinib is a targeted therapy that plays an important role in the treatment ···【more】
Release date：2025-03-07Recommended：98
Osimertinib is an important drug for the treatment of non-small cell lung cancer···【more】
Release date：2025-03-07Recommended：58
